- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 1.83M sh |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 358.34K sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | −$1.69M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$3.49M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $946K |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $2.67M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $3.53M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $6.03M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $13.15M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $6.66M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $2.38M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $2.43M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $2.4M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $2.45M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $2.14M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $4.42M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $5.93M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $8.48M |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | −$1.35 |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$18.25 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | −$1.35 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$18.25 |
| Sga Expense | Q1 2025 · Mar 31, 2025 | $2.52M |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $6.15M |
| Net Income | Q1 2025 · Mar 31, 2025 | −$2.48M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$6.54M |
| Operating Income | Q1 2025 · Mar 31, 2025 | −$2.56M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$6.59M |
| Gross Profit | Q1 2025 · Mar 31, 2025 | −$21K |
| Gross Profit | Q1 2025 · Mar 31, 2024 | −$17K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2025 | $22K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $21K |
| Revenue | Q1 2025 · Mar 31, 2025 | $1K |
| Revenue | Q1 2025 · Mar 31, 2024 | $4K |
| Capex | Q1 2025 · Mar 31, 2024 | $839K |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $395K |